Compound Education
Why Tesamorelin Is Suddenly Everywhere in Canada
Developed in Montreal, approved by Health Canada in 2014 and later discontinued here. Why a niche Canadian compound is suddenly...
Dihexa: Hype vs. Evidence
One of the most quoted potency figures in the field, and one of the emptiest evidence files. Worth separating the...
What Are Peptide Bioregulators?
The shortest sequences on the shelf, grouped by organ rather than effect, with the widest gap between what is claimed...
Semaglutide, Tirzepatide, Retatrutide: What’s the Difference?
A receptor-level breakdown of how Semaglutide, Tirzepatide, and Retatrutide differ, and what each generation of incretin-based peptide adds to the...
Retatrutide and Cardiovascular Health: What You Need to Know
What current research shows about Retatrutide's cardiovascular and cardiometabolic profile, why the triple receptor mechanism is relevant, and what Phase...
BPC-157 and Gut Health: What the Research Actually Shows
BPC-157's most thoroughly characterised research area is gastrointestinal. A look at the gut lining, NSAID protection, the gut-brain axis, and...
MOTS-c Explained: The Energy Peptide Built for Longevity
MOTS-c is a mitochondrially-encoded peptide that declines with age. What the research shows about its role in energy metabolism, insulin...
